SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Thomson Reuters Corporation (TRI.TO) trades at a trailing P/E of 35.7, forward P/E of 28.0. Trailing earnings yield is 2.81%, forward earnings yield 3.58%. PEG 1.02.
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 28.0 (down from trailing 35.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.02 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 2.81% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.58% as earnings recover.
Overall SharesGrow Score: 58/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — TRI.TO
Valuation Multiples
P/E (TTM)35.7
Forward P/E28.0
PEG Ratio1.02
Forward PEG1.02
P/B Ratio0.00
P/S Ratio7.16
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3.40
Forward EPS (Est.)$4.34
Book Value / Share$0.00
Revenue / Share$16.92
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.81%
Forward Earnings Yield3.58%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$4.72 |
$11.17B |
$3.1B |
27.7% |
| 2017 |
$2.22 |
$11.33B |
$1.4B |
12.3% |
| 2018 |
$6.13 |
$5.5B |
$3.95B |
71.8% |
| 2019 |
$4.48 |
$5.91B |
$2.17B |
36.7% |
| 2020 |
$3.53 |
$5.98B |
$1.69B |
28.3% |
| 2021 |
$-1.16 |
$6.35B |
$-553M |
-8.7% |
| 2022 |
$3.89 |
$6.63B |
$1.89B |
28.5% |
| 2023 |
$5.69 |
$6.79B |
$2.7B |
39.7% |
| 2024 |
$4.89 |
$7.26B |
$2.21B |
30.4% |
| 2025 |
$3.40 |
$7.61B |
$1.53B |
20.1% |
